Hyperhidrosis clinical trials

The registry lists 111 studies for Hyperhidrosis across more than 10 countries. 10 are recruiting or about to start. 108 of them are mainly about Hyperhidrosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-10.

Get an email when these change. Save the Hyperhidrosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 85
Terminated: 8
Recruiting: 7
Status unknown: 5
Not yet recruiting: 3
Withdrawn: 3

Phase

Phase 2: 25
Phase 3: 15
Phase 1: 9
Phase 4: 8

Where

United States: 55
Egypt: 8
Brazil: 7
Germany: 7
Canada: 5
Sweden: 4

Who runs them

Botanix Pharmaceuticals (9) · Journey Medical Corporation (6) · Ulthera, Inc (6) · Allergan (5) · Dr. August Wolff GmbH & Co. KG Arzneimittel (4) · University of Utah (3) · University of Sao Paulo (3) · Cynosure, Inc. (3)

What is being tested here

Drugs under test in Hyperhidrosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Oxybutynin	1	2	8
Botulinum toxin type A	0	2	12
Glycopyrrolate	0	0	5
Sofpironium	0	0	4
WO3970	0	1	3
GSK573719	0	0	3
rimabotulinumtoxinB	0	0	2
Ethanol	0	0	1
Terazosin	0	0	1
Magnesium	0	0	1

Drug classes tested here Antimuscarinics 1 open

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Oct 202720% Alcohol With Steroid Local Anesthetic Technique Versus Steroid Local Anesthetic Technique Only in Stellate Ganglion Injection in Idiopathic Palmar Hyperhydrosis · Fayoum University Hospital
Oct 2027"Incidence of Compensatory Hyperhidrosis After T3 Vs T3-4 Sympathectomy" · Assiut University

Who these studies take

Of the 7 Hyperhidrosis studies recruiting now, 4 (57%) set no upper age limit and 3 (43%) stop at 75 or younger. 1 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (29%) take healthy volunteers.

Recruiting studies that take each age, of 7
Age	Women	Men
10	0 (0%)	0 (0%)
18	7 (100%)	7 (100%)
30	7 (100%)	7 (100%)
40	7 (100%)	7 (100%)
50	5 (71%)	5 (71%)
65	5 (71%)	5 (71%)
75	5 (71%)	5 (71%)
85	4 (57%)	4 (57%)

Across all 111 studies, recruiting or not: 56% stop at 75 or younger and 41% at 65; 28% take children; 1% are for women only and 3% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperhidrosis studies take

Of 14 phase 2 interventional studies under Hyperhidrosis, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 2	8 mo7–11 · 14 studies	—	—
Interventional, no phase	21 mo6–37 · 20 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 111. Browse all 111 → or search them.